From this morning’s New York Times:

“Even scientists who believe that the restrictions on embryonic stem cell research have been harmful are concerned about the overstatements. “We don’t know yet how valuable this technology is going to be,” said Thomas Cech, president of the Howard Hughes Medical Institute. “All of a sudden, the content increases in value just because you can’t have it,” Dr. Cech said.”

It’s in the spirit of what Ramesh and Charles Krauthammer write today – but it’s in the Times! And from a biotech guy!: